Skip to content

Evaluate the effect of Rasanjanadi Aschyotan in netra Abhishyand w.s.r. to Infective Conjunctivitis.

A clinical study on the effect of Rasanjanadi Aschyotan(eye drops) in the Management of Netra Abhishyand w.s.r to Infective Conjunctivitis - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/09/057326
Enrollment
20
Registered
2023-09-06
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H109- Unspecified conjunctivitis

Interventions

None listed

Sponsors

Principal R.G.G.P.G.Ayurvedic College And Hospital,Paprola
Lead Sponsor
Dr Sukhdev Singh
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: a. Patient willing for trail b. Patients presenting with symptoms of Netra Abhishyand w.s.r. to infective Conjunctivitis .

Exclusion criteria

Exclusion criteria: a. Patient not willing to undergo trial b. Eye disease like squamous blepharitis, corneal ulcer, lagopthalmus, dacryocystitis, uveitis, any stage of glaucoma, very severe conjunctivitis. c. Patient suffering from dry eye associated with other ocular disease or systemic disease where trial is not feasible.

Design outcomes

Primary

MeasureTime frame
Effect of Rasanjanadi Aschyotan (drops) in relieving the symptoms of Netra AbhishyandTimepoint: 1 week

Secondary

MeasureTime frame
1.Evaluate the effect of Rasanjanadi Aschyotan (Eye drops) in the management of Netra Abhishyand . 2.To study the untoward effect of drugs if any after 1 weekTimepoint: 1 week

Countries

India

Contacts

Public ContactDr Abhishek Kangoo

RGGPG Ayurvedic College and Hospital Paprola

drsukhdev@gmail.com9418471230

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026